The aim is to (1) establish a system of multimodal imaging technology; (2) jointly apply multimodal imaging technology to diagnose of cardiac allograft vasculopathy of heart transplantation; (3) construct a multimodal imaging technology prediction model of adverse events, screening the best non-invasive imaging prediction indicators.
This study will enrolled 1000 HT patients, and the cardiac allograft vasculopathy will be evaluated by multimodal imaging technology. The aim is to (1) establish a system of multimodal imaging technology; (2) jointly apply multimodal imaging technology to diagnose of cardiac allograft vasculopathy of heart transplantation; (3) construct a multimodal imaging technology prediction model of adverse events, screening the best non-invasive imaging prediction indicators.
Study Type
OBSERVATIONAL
Enrollment
1,000
All cause death
All cause death after HT was obtained via telephone interview with family members; contact with his/her physicians; or hospital records
Time frame: up to 10 year
Major adverse cardiac events
Major adverse cardiac events after the inclusion of the study was obtained via telephone interview with family members; contact with his/her physicians; or hospital records
Time frame: 5 year and 10 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.